From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders - Kozlowska - 2022 - Journal of Neurochemistry - Wiley Online Library
Psychotropic vs. Psychedelics vs. Psychoactive: A Guide - Restore Mental Health | Inpatient & Outpatient Treatment
Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year | Hypertension
Psychedelics for treating psychiatric disorders: Are they safe? | MDedge Psychiatry
Hallucinogens: LSD, Peyote, Psilocybin, PCP & Other Psychedelic Drugs
Mind menders: how psychedelic drugs rebuild broken brains | New Scientist
Frontiers | Psychedelics, Sociality, and Human Evolution
Mental health, personality and lifetime psychedelic use during the COVID-19 pandemic | medRxiv
Psychedelics - Alcohol and Drug Foundation
LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making | Psychological Medicine | Cambridge Core
Interest Grows in Treatment of Mood Disorders by Classic Psychedelics
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice - ScienceDirect
Psychedelics as Transformative Therapeutics | American Journal of Psychiatry
Pharmaceuticals | Free Full-Text | New Paradigms of Old Psychedelics in Schizophrenia
Psychiatric and nonpsychiatric indications for mood stabilizers and select antiepileptics | MDedge Psychiatry
Psychedelics and Neural Plasticity: Therapeutic Implications | Journal of Neuroscience
LSD-Like Molecules Counter Depression Without the Trip | UC San Francisco
Psychiatrist Explores Benefits Of Treating PTSD With Ecstasy And Cannabis : Shots - Health News : NPR
Psychedelics and Hallucinogens - Mechanisms of Action and Clinical Application
Classic Hallucinogens in Neurology - Practical Neurology
Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research - ScienceDirect